Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-11-068626)

Filing Details

Accession Number:: 0001104659-11-068626
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2011-12-09 16:07:27
Reporting Period:: 2011-11-22

Filing Date:: 2011-12-09
Accepted Time:: 2011-12-09 16:07:27
Original Submission Date:: 2011-11-22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093649	Idenix Pharmaceuticals Inc	IDIX	Pharmaceutical Preparations (2834)	450478605

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1030617	Ag Pharma Novartis	Lichstrasse 35 Basel V8 CH4002		No	No	Yes	No
1114448	Ag Novartis	Lichstrasse 35 Basel V8 CH4002		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-11-22	6,476	$2.96	33,202,903	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2011-11-22	20,288	$4.70	33,224,477	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

Price is corrected from $2.95 to $2.96.
These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG. Novartis AG is an indirect beneficial owner of these securities. See attachment.
The amount of securities acquired is corrected from 20,228 to 20,288.